Plasmapheresis cost, safety and procedure: what to expect

Plasmapheresis cost varies widely: it is not just a machine fee, but a medical protocol shaped by indication, processed volume, replacement fluid, pre/post labs, venous access, physician oversight and follow-up. That is why quotes should not be compared as standalone wellness sessions.

Plasmapheresis is an extracorporeal blood filtration procedure that draws blood, separates plasma from cellular components and reduces inflammatory proteins, autoantibodies or high-molecular-weight molecules before returning blood cells to the patient. In preventive and longevity medicine, it should only be considered with medical assessment, biomarkers, medication review and a measurable objective — not as generic detox.

The name sounds more complicated than the procedure actually is: it is closer to a long blood donation than to surgery. It takes 2-3 hours, with the patient awake and comfortable, while a machine does the filtration work. For evidence, cost and safety framing, read our guide to therapeutic plasma exchange.

What plasmapheresis actually is (and what it is not)

There is frequent confusion between three terms that get used interchangeably but are not identical:

• Plasmapheresis: a general term for any procedure that separates plasma from blood. This includes plasma donation as well as therapeutic exchange.
• Therapeutic plasma exchange (TPE): a procedure where plasma containing pathogenic or clinically relevant circulating factors is removed and replaced with albumin or compatible donor plasma.
• Membrane plasmafiltration: a variant that uses filters with specific pore sizes to retain large molecules (inflammatory proteins, autoantibodies, immune complexes) and return filtered plasma to the patient.

The difference from dialysis is straightforward: dialysis filters small molecules (urea, creatinine, electrolytes) in patients with kidney failure. Plasmapheresis filters large molecules from plasma — proteins, antibodies, inflammatory mediators — in conditions where those molecules are causing harm. They are complementary procedures, not interchangeable.

According to StatPearls (Pham & Schwartz, updated 2023), the American Society for Apheresis (ASFA) classifies therapeutic plasmapheresis indications into four categories, from first-line treatment (Category I) to experimental use (Category IV), covering more than 80 distinct clinical conditions.

Preparation: what to do before the session

Preparation for a plasmapheresis session does not require complicated protocols, but several points matter:

• Pre-procedure blood work: complete blood count, calcium levels, fibrinogen, and coagulation profile. In our programs, these labs are done before arrival or on the first day of your stay.
• Hydration: drink 500-750 ml of water in the 2 hours before the session. A well-hydrated patient tolerates the procedure better and makes venous access easier.
• Light meal: do not come fasting. A light meal 1-2 hours before prevents hypoglycemia during the procedure.
• Medications: inform the medical team about all medications, particularly ACE inhibitors (relative contraindication; should be stopped 24 hours before) and anticoagulants.
• Comfortable clothing: sleeves that roll up easily for access on both arms.

The procedure step by step

Here is how a typical membrane plasmapheresis session unfolds, from the moment you sit down to the moment you finish:

1. Venous access (10-15 minutes)

Two peripheral IV lines are placed — one in each arm (one for blood withdrawal, one for return) — or in some cases a dual-lumen central venous catheter. Local anesthesia is applied at the puncture site. For most outpatients, peripheral access with large-bore needles is sufficient.

2. Baseline samples (5 minutes)

The first 3-5 ml of blood are discarded from the access line, and baseline samples are drawn: complete blood count, serum calcium, and fibrinogen. These values serve as the reference for post-procedure comparison.

3. Machine connection and priming (5-10 minutes)

The lines are connected to the apheresis device. The machine calculates the patient's effective plasma volume using the formula: total blood volume × (1 – hematocrit). For a 70 kg person with a 42% hematocrit, the plasma volume is approximately 2,900 ml. The circuit is primed with heparinized saline.

4. Separation and filtration (90-120 minutes)

This is where the real work happens. Blood flows at a rate of 30-50 ml/min through the membrane filter. The filter pores (between 0.2 and 0.5 microns, depending on type) retain large molecules — immunoglobulins, immune complexes, fibrinogen, lipoproteins — while allowing filtered plasma and blood cells to pass through.

A study by Mehdipour et al. (2020, PMID: 32474458) reported that plasma dilution in old mice improved tissue and blood-marker signals, reducing selected pro-inflammatory factors and changing progenitor-cell function across three germ-layer tissues. It is relevant preclinical evidence, not proof of clinical rejuvenation in humans.

During this phase, an anticoagulant (sodium citrate or heparin) is administered to prevent clotting in the extracorporeal circuit. Citrate is most commonly used because its effect is reversible and it metabolizes quickly.

5. Reinfusion and completion (15-20 minutes)

Once the target volume has been processed (typically 1-1.5 plasma volumes, or 40-60 ml/kg), the machine initiates the final reinfusion. All blood remaining in the circuit is returned. Post-procedure samples for calcium and fibrinogen are drawn. IV lines are removed and local pressure is applied.

Procedure phase	Approximate duration	What happens
Venous access	10-15 min	IV placement in both arms or central catheter
Baseline samples	5 min	Reference labs: calcium, fibrinogen, blood count
Circuit priming	5-10 min	Machine setup and plasma volume calculation
Separation and filtration	90-120 min	Plasma filtration through membrane
Reinfusion	15-20 min	Return of residual blood, post-procedure labs, line removal
Total	2-3 hours	Complete outpatient procedure

What it feels like during plasmapheresis

The most common question. The reality: most patients describe the experience as "boring" rather than uncomfortable. You sit or recline for 2-3 hours with your arms relatively still.

Typical sensations during the procedure:

• Tingling in lips, fingers, or around the mouth: the most common signal, caused by a temporary drop in ionized calcium due to citrate. According to the American College of Rheumatology, this occurs in 20-30% of patients. It resolves by adjusting the citrate infusion rate or giving IV calcium.
• Feeling cold: blood circulates outside the body and loses temperature. Managed with warm blankets.
• Mild nausea: in fewer than 10% of cases, associated with volume shifts or citrate.
• Pressure or tightness in the arm: from the IV lines. Not sharp pain.
• Post-procedure fatigue: moderate tiredness for 12-24 hours afterward is normal. The body is replenishing plasma proteins.

A reassuring datapoint: a retrospective study by Mokrzycki & Kaplan (1994, PMID: 7832113) covering more than 4,800 plasmapheresis procedures documented a serious complication rate below 0.5%. The vast majority of adverse effects are mild and self-limiting.

Monitoring during the procedure

The medical team does not leave you alone with the machine. Continuous monitoring includes:

• Blood pressure: every 15-30 minutes. Plasma volume reduction can cause hypotension, especially in patients with low body weight or dehydration.
• Heart rate: to detect compensatory tachycardia.
• Oxygen saturation: continuous pulse oximetry.
• Ionized calcium: the single most important parameter. Citrate chelates calcium, and low levels can range from tingling to arrhythmias in extreme cases. Many centers administer prophylactic IV calcium gluconate.
• Temperature: to detect febrile reactions.
• Machine flow and transmembrane pressure: technical parameters indicating filter performance.

When the procedure is stopped

The medical team may interrupt the session if any of the following occur:

• Hypotension unresponsive to IV fluids
• Cardiac arrhythmia
• Allergic reaction to replacement fluid (urticaria, dyspnea, anaphylaxis)
• Symptomatic hypocalcemia unresponsive to supplementation
• Technical problems with venous access (line clotting, inadequate flow)
• Patient request

This happens in fewer than 3% of sessions, according to the StatPearls review. The decision to stop always takes priority over completing the target volume.

Side effects: common and rare

Every medical procedure has side effects. With plasmapheresis, most are predictable and manageable:

Side effect	Frequency	Cause	Management
Perioral tingling	20-30%	Citrate-induced hypocalcemia	Reduce rate, IV calcium
Fatigue	30-50%	Transient protein depletion	Rest, hydration, protein intake
Dizziness/mild hypotension	10-20%	Transient volume reduction	Trendelenburg position, IV fluids
Nausea	5-10%	Citrate, volume shifts	Antiemetics if persistent
Puncture-site bruising	5-15%	Peripheral venous access	Compression, local ice
Allergic reaction	<1%	Replacement fluid	Antihistamines, epinephrine if severe
Catheter infection	<1% (central line only)	Central venous access	Antibiotics, catheter removal

Kiprov et al. published a review in Transfusion and Apheresis Science (2021, PMID: 34074614) on plasma exchange, blood products and longevity. It is useful for understanding hypotheses and cautions, but it does not replace an individual medical indication or prove clinical benefit in healthy people.

Immediate recovery and post-session care

After the session ends:

• The first 30 minutes: you remain under observation. Blood pressure, heart rate, and general wellbeing are checked. A glass of water and a protein-rich snack are recommended.
• The first 24 hours: avoid intense exercise and alcohol. Your body is regenerating the plasma proteins that were removed — fibrinogen, immunoglobulins, albumin. The liver synthesizes these proteins within 24-48 hours.
• Hydration: drink at least 2 liters of water in the following 24 hours.
• Nutrition: meals rich in quality protein (fish, eggs, legumes) to supply the amino acids the liver needs for resynthesis.

Most patients return to normal activity the next day. No medical leave or special rest is needed beyond the first 24 hours.

Plasmapheresis in longevity medicine: why Progevita evaluates it

Plasmapheresis is not only a procedure for autoimmune diseases. Since 2020, part of longevity research has examined a narrower hypothesis: some factors related to inflammation, immune signaling and aging circulate in blood plasma and may change with selected exchange protocols.

The study by Mehdipour et al. (2020, Aging, PMID: 32474458) was a turning point. Researchers at Irina and Michael Conboy's lab at UC Berkeley reported that diluting old plasma with saline and albumin improved functional signals in tissues from all three germ layers: brain (ectoderm), liver (endoderm), and muscle (mesoderm). Young plasma was not needed. The working hypothesis was to reduce the concentration of accumulated pro-inflammatory factors.

A follow-up study by Mehdipour et al. (2022, PMID: 35999337) in human volunteers reported reductions in p16 levels in peripheral blood mononuclear cells — a marker of cellular senescence — and changes in the lymphoid-to-myeloid ratio. That is compatible with a more favorable immune profile, but it is still biomarker evidence rather than proof of clinical rejuvenation.

And in 2025, an exploratory trial with a simulated-procedure arm (Fuentealba et al., Aging Cell, DOI: 10.1111/acel.70103) with 42 participants showed biological-age signals, especially when TPE was combined with immunoglobulin. Promising, but not a universal anti-aging indication: the study was small, short-term and needs independent replication.

Caution increased with Borsky et al. (2025, PMID: 40592961), a healthy-donor trial that found no epigenetic rejuvenation after repeated plasmapheresis without albumin or young-plasma replacement. Protocol, patient and goal matter.

At Progevita, membrane plasmapheresis is assessed inside a broader clinical strategy: medical history, lab work, inflammation biomarkers, measurable goals and individual risk review. We do not publish a closed Progevita price here, because the real cost depends on protocol, replacement fluid, lab work and whether it sits inside a broader medical program.

The clinical logic is not “blood cleaning.” It is asking whether reducing specific plasma signals may improve a biomarker or clinical objective, and whether less invasive levers —sleep, strength training, nutrition, ApoB control, visceral-fat reduction— are already covered. If combined with ozone therapy, NAD+ IV or other treatments, it should be because there is a medical rationale, not because more technology is automatically better.

Our medical team evaluates each case to determine whether plasmapheresis is indicated, what type of filtration is needed, and how to integrate it into the overall longevity plan. The procedure is performed at the Balneario de Cofrentes clinical facilities under medical supervision. Without labs, a responsible physician and a stopping rule, the headline price says very little.

Frequently asked questions

How long does a plasmapheresis session last?

A complete session takes between 2 and 3 hours, including preparation, filtration (90-120 minutes), and post-procedure observation. It does not require hospital admission; it is an outpatient procedure.

Does plasmapheresis hurt?

The only uncomfortable moment is the needle or catheter insertion, similar to a blood draw. There is no pain during the procedure. The most common sensations are lip tingling (from citrate) and feeling cold, both of which are manageable.

What is the difference between plasmapheresis and dialysis?

Dialysis filters small molecules (urea, creatinine) and is indicated for kidney failure. Plasmapheresis filters large molecules from plasma (proteins, antibodies, inflammatory mediators) in selected medical indications; longevity use remains investigational. They filter different things.

How many plasmapheresis sessions are needed?

It depends on the goal. For autoimmune diseases, a cycle may include several sessions on alternate days depending on the indication. In longevity medicine, use remains investigational and there is no standard schedule: it is individualized by clinical objective, biomarkers, risk, replacement fluid and response.

What are the side effects of plasmapheresis?

The most common are perioral tingling (20-30%), transient fatigue (30-50%), and mild dizziness (10-20%). Serious complications (allergic reaction, infection) occur in fewer than 1% of cases. The safety profile is favorable when performed at an experienced facility.

How much does plasmapheresis cost?

Price depends on protocol, number of sessions, replacement fluid, pre/post labs, venous access and medical supervision. As market context —not approved Progevita pricing— private sessions usually sit in four-figure budgets. At Progevita, cost is assessed inside a plan with diagnostics, clinical goals, follow-up and stopping rules.

Can plasmapheresis reverse aging?

Evidence suggests that some plasma exchange protocols can change inflammatory, proteomic and biological-age markers, but this does not prove guaranteed rejuvenation. Fuentealba et al. (2025) showed promising signals; Borsky et al. (2025, PMID: 40592961) found no epigenetic rejuvenation in healthy donors. The correct reading is: investigational longevity tool, not a fountain of youth.

References

1. Pham HP, Schwartz J, "Therapeutic Plasma Exchange", StatPearls, updated 2023 (available at NBK560566)
2. Mehdipour M et al., "Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin", Aging, 2020 (PMID: 32474458)
3. Mehdipour M et al., "Old plasma dilution reduces human biological age: a clinical study", GeroScience, 2022 (PMID: 35999337)
4. Fuentealba M et al., "Therapeutic plasma exchange with intravenous immunoglobulin reduces biological age in older adults", Aging Cell, 2025 (DOI: 10.1111/acel.70103)
5. Borsky P et al., "Repeated plasmapheresis does not rejuvenate epigenetic age in healthy blood donors", Scientific Reports, 2025 (PMID: 40592961)
6. Kiprov DD et al., "Therapeutic plasma exchange (TPE) and blood products – Implications for longevity and disease", Transfusion and Apheresis Science, 2021 (PMID: 34074614)
7. Mokrzycki MH, Kaplan AA, "Therapeutic plasma exchange: complications and management", American Journal of Kidney Diseases, 1994 (PMID: 7832113)
8. Conboy IM et al., "Rejuvenation of aged progenitor cells by exposure to a young systemic environment", Nature, 2005 (PMID: 15703760)

This article is for informational purposes and does not replace medical consultation. Any plasmapheresis procedure should be evaluated and indicated by a qualified healthcare professional.

Interested in finding out whether plasmapheresis could be part of your longevity plan? Book a consultation with our medical team and design a personalized program at Balneario de Cofrentes.